Correlative analyses of serum biomarkers and clinical outcomes in the phase 2 study of lenvatinib, everolimus, and the combination, in patients with metastatic renal cell carcinoma following 1 VEGF-targeted therapy Meeting Abstract
| Authors: | Glen, H.; Hsieh, J.; Michaelson, M. D.; Kim, H. J.; Sachdev, P.; Kadowaki, T.; Funahashi, Y.; Larkin, J.; Motzer, R. |
| Abstract Title: | Correlative analyses of serum biomarkers and clinical outcomes in the phase 2 study of lenvatinib, everolimus, and the combination, in patients with metastatic renal cell carcinoma following 1 VEGF-targeted therapy |
| Meeting Title: | 18th European Cancer Conference (ECCO 18) |
| Journal Title: | European Journal of Cancer |
| Volume: | 51 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2015 Sep 25-29 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S89 |
| Language: | English |
| ACCESSION: | WOS:000361887400273 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(16)30266-0 |
| Notes: | Meeting Abstract: 432 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
